163 related articles for article (PubMed ID: 25488212)
1. Affine registration of [123I]FP-CIT SPECT brain images.
Salas-Gonzalez D; Górriz JM; Ramírez J; A Illán I; Padilla P; Martínez-Murcia FJ; Lang EW
Stud Health Technol Inform; 2014; 207():65-73. PubMed ID: 25488212
[TBL] [Abstract][Full Text] [Related]
2. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
3. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
4. Building a FP-CIT SPECT Brain Template Using a Posterization Approach.
Salas-Gonzalez D; Górriz JM; Ramírez J; Illán IA; Padilla P; Martínez-Murcia FJ; Lang EW
Neuroinformatics; 2015 Oct; 13(4):391-402. PubMed ID: 25749984
[TBL] [Abstract][Full Text] [Related]
5. Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).
Skanjeti A; Angusti T; Iudicello M; Dazzara F; Delgado Yabar GM; Trevisiol E; Podio V
J Neuroimaging; 2014; 24(3):257-65. PubMed ID: 23323544
[TBL] [Abstract][Full Text] [Related]
6. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
7. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
8. Weighted registration of 123I-FP-CIT SPECT images improves accuracy of binding potential estimates in pathologically low striatal uptake.
Ciarmiello A; Giovacchini G; Guidotti C; Meniconi M; Lazzeri P; Carabelli E; Mansi L; Mariani G; Volterrani D; Del Sette M
J Cell Physiol; 2013 Oct; 228(10):2086-94. PubMed ID: 23559000
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines.
Oliveira FP; Castelo-Branco M
J Neural Eng; 2015 Apr; 12(2):026008. PubMed ID: 25710187
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
[TBL] [Abstract][Full Text] [Related]
11. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
[TBL] [Abstract][Full Text] [Related]
12. A robust computational solution for automated quantification of a specific binding ratio based on [123i]fp-cit SPECT images.
Oliveira FP; Borges Faria D; Campos Costa D; Tavares JM
Q J Nucl Med Mol Imaging; 2014 Mar; 58(1):74-84. PubMed ID: 24145318
[TBL] [Abstract][Full Text] [Related]
13. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
14. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
15. Use of the BasGan algorithm for [123I]FP-CIT SPECT quantification: a phantom study.
Poli GL; Bianchi C; Guerra UP
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):391-400. PubMed ID: 23752689
[TBL] [Abstract][Full Text] [Related]
16. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
18. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of the dopaminergic neurotransmission system using [123I]FP-CIT SPECT in 6-OHDA lesioned rats.
Niñerola-Baizán A; Rojas S; Bonastre M; Tudela R; Lomeña F; Pavía J; Marin C; Ros D
Contrast Media Mol Imaging; 2015; 10(1):67-73. PubMed ID: 24888455
[TBL] [Abstract][Full Text] [Related]
20. Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients.
Hida K; Nonokuma M; Kuwabara Y; Tani T; Takano K; Yoshimitsu K
Ann Nucl Med; 2016 Aug; 30(7):477-83. PubMed ID: 27225162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
